Arca
Skip to content
Tools
Tools

HeartFlow Analysis

Coronary Vascular Physiologic Simulation Software. 510(k) K250902, from HeartFlow, Inc. (Mountain View, CA). Product code PJA, class 2.

As of Nov 18, 2026, K250902 is an FDA 510(k) held by HeartFlow, Inc., substantially equivalent on Jul 18, 2025 after 114 days, with no recalls tied to it in FDA's recall database.

  • Review time: 114 days
  • Recalls: 0

Indications for use

As the 510(k) summary states them, read from FDA's summary PDF

The Heartflow Analysis is an AI-based medical device software for the clinical quantitative and qualitative analysis of previously acquired Computed Tomography DICOM data for adult patients (ages 22 years and older) with suspected coronary artery disease.

Predicate devices

The legally marketed devices this 510(k) summary says it is substantially equivalent to, read from FDA's summary PDF

Other PJA clearances

The newest 510(k)s for the same product code; their median review was 133 days; see every PJA device

Elsewhere

Record

Type
Traditional
Received
Mar 26, 2025
Review panel
Cardiovascular
Regulation
21 CFR 870.1415

One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files

Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.